Takeda Pharmaceutical Co., Ltd. revenue breakdown overview

Takeda Pharmaceutical Co., Ltd. revenue for the last year amounted to 30.31 B USD, the most of which — 8.24 B USD — came from its highest performing source at the moment, Gastrointestinal, the year earlier bringing 7.19 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought Takeda Pharmaceutical Co., Ltd. 15.84 B USD, and the year before that — 14.08 B USD.